Hematological adverse effects in breast cancer patients treated with cyclin-dependent kinase 4 and 6 inhibitors: a systematic review and meta-analysis
Crossref DOI link: https://doi.org/10.1007/s12282-017-0818-4
Published Online: 2017-11-16
Published Print: 2018-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kassem, Loay
Shohdy, Kyrillus S.
Lasheen, Shaimaa
Abdel-Rahman, Omar
Bachelot, Thomas
License valid from 2017-11-16